ArchimMed SARL, 12, rue Charles de Gaulle, 78350, Jouy en Josas, France.
Occlugel, 12, rue Charles de Gaulle, 78350, Jouy en Josas, France.
Pharm Res. 2018 Aug 15;35(10):191. doi: 10.1007/s11095-018-2474-6.
To assess the lymphatic transport of microparticles of 100 nm, 1 μm and 10 μm subcutaneously injected into the breast area of healthy and tumor-bearing rabbits, and to analyze their location in lymph node (LN) in relation to malignant cells.
Female rabbits (n = 9) bearing a VX2 tumor in one thoracic mammary gland were subcutaneously injected at D15 with polystyrene fluorescent particles around the nipple, on the tumor and on the healthy sides. The tumor and the LN measured by ultrasound at D9, D15 and D20 were explanted at D20. The LN metastases were evaluated by cytokeratin staining. LN uptake of the particles was measured by quantifying the green fluorescence surface in hot spot regions of healthy and pathologic LN.
All animals developed mammary tumors. Metastases were found in 39% of LN from the tumor side. LN invasion was significantly lower for the 10 μm group versus the 100 nm group (p < 0.0348). The fully invaded area of metastatic LN contained significantly less 100 nm and 1 μm particles compared to the low and non-invaded regions and to the healthy LN. In the invaded LN, the 1 μm MS occupied more surface than the 100 nm particles.
1 μm MS arrived numerously into the areas low-invaded and non-invaded by the tumoral cells of the pathologic LN, but they were very rare in the fully invaded regions. Compared to the 100 nm nanospheres, the 1 μm were better retained (20 times) into the sentinel LN, showing the advantage of micrometric particles for lymph-targeted chemotherapy when injected before complete invasion by metastases.
评估 100nm、1μm 和 10μm 粒径的微粒经皮下注射到健康和荷瘤兔乳房区域后的淋巴转运,并分析其在淋巴结(LN)中的位置与恶性细胞的关系。
在第 15 天,在一只胸乳头上有 VX2 肿瘤的雌性兔中,在乳晕周围、肿瘤上和健康侧皮下注射聚苯乙烯荧光微球。在第 9、15 和 20 天通过超声测量肿瘤和 LN,并在第 20 天取出 LN。通过细胞角蛋白染色评估 LN 转移。通过在健康和病理性 LN 的热点区域定量测量绿色荧光表面来测量 LN 对微粒的摄取。
所有动物均形成了乳腺肿瘤。在肿瘤侧的 LN 中发现了 39%的转移。10μm 组的 LN 侵犯率明显低于 100nm 组(p<0.0348)。转移性 LN 的完全侵犯区域中,100nm 和 1μm 微粒的含量明显低于低侵犯和非侵犯区域以及健康 LN。在侵犯的 LN 中,1μm MS 占据的表面比 100nm 颗粒多。
1μm MS 大量进入病理性 LN 中肿瘤细胞低侵犯和未侵犯的区域,但在完全侵犯区域中非常罕见。与 100nm 纳米球相比,1μm 微粒在 sentinel LN 中的保留率(20 倍)更高,这表明在完全被转移侵犯之前注射时,微米级颗粒对于淋巴靶向化疗具有优势。